Arrowhead Research | ARWR - Loan Capital



Arrowhead Research reported $200.33M in Loan Capital for its fiscal quarter ending in June of 2025.


Loan Capital Change Date
Agios Pharmaceuticals USD 0 0 Mar/2025
Alnylam Pharmaceuticals USD 1.03B 956K Jun/2025
Arrowhead Research USD 200.33M 8.59M Jun/2025
Incyte USD 31.76M 883K Jun/2025
Ionis Pharmaceuticals USD 625.49M 625.22M Jun/2025
Ligand Pharmaceuticals USD 0 0 Mar/2025
Merck USD 33.97B 484M Jun/2025
Moderna USD 32M 3M Jun/2025
Novartis USD 24.06B 2.4B Jun/2025
Sarepta Therapeutics USD 1.14B 1.17M Jun/2025
TG Therapeutics USD 245.04M 608K Jun/2025
Ultragenyx Pharmaceutical USD 782.75M 782.75M Jun/2025
Vertex Pharmaceuticals USD 112.8M 1.2M Dec/2024
Xencor USD 94.74M 7.1M Jun/2025